---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-23-001036"
form_type: "8-K"
ticker: "KAVL"
cik: "0001762239"
company_name: "Kaival Brands Innovations Group, Inc."
filed_at: "2023-05-31T23:59:59+00:00"
generated_at: "2026-06-14T10:40:35.470605+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Kaival Brands acquires GoFire's vaporizer patent portfolio for equity; appoints new director

## Summary
- Acquired 12 issued and 46 pending patents on vaporizer/inhalation tech for 2M common shares, 900K Series B Preferred, and warrants for 2M common.
- Series B Preferred redeemable at $15/share, convertible into 8.3333 common shares per preferred, with 2% cumulative dividend and limited conversion after 18 months.
- Contingent cash payments: 50% of cannabis-specific royalties up to $15M, then 10% until 2027; warrants have exercise prices of $3-$6 per share.
- Board expanded to 8; James P. Cassidy appointed as Series B Preferred Director, designated by GoFire.
- Transaction closed May 30, 2023; assets housed in wholly owned subsidiary Kaival Labs.

## SEC filing metadata
- accession: 0001731122-23-001036
- form_type: 8-K
- ticker: KAVL
- cik: 0001762239
- company_name: Kaival Brands Innovations Group, Inc.
- filed_at: 2023-05-31T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.01, 3.02, 3.03, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1762239/000173112223001036/0001731122-23-001036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1762239/000173112223001036/e4751_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-23-001036
- JSON: https://secwatch.observer/filing/0001731122-23-001036.json
- Plain text: https://secwatch.observer/filing/0001731122-23-001036.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
